Add-on Acquisition • Life Science

Lumicera Acquires Quality Drug

On July 19, 2021, Lumicera acquired life science company Quality Drug

Acquisition Context

This is Lumicera’s 1st transaction in the Life Science sector.
This is Lumicera’s 1st transaction in the United States.
This is Lumicera’s 1st transaction in California.

Explore All 3109 Add-on Acquisition Life Science Deals - Search the Database Free

M&A Deal Summary
Date	July 19, 2021
Target	Quality Drug
Sector	Life Science
Buyer(s)	Lumicera
Deal Type	Add-on Acquisition

Target Company

Quality Drug

Irvine, California, United States

Quality Drug provides complete specialized care, with a range of medications, therapies, and services to making managing your condition easier. Quality Drug is based in Irvine, California.

Explore More Deals

Browse All 215,156 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Lumicera

Madison, Wisconsin, United States

Category	Company
Founded	2014
Sector	Life Science

DESCRIPTION

Lumicera provides specialty pharmacy solutions framed in the core principles of transparency and stewardship. Lumicera offers specialty pharmacy care, one patient at a time, through educational, clinical, financial and service excellence. Lumicera was founded in 2014 and is based in Madison, Wisconsin.

Deal Context for Buyer	#
Overall	1 of 1
Sector: Life Science	1 of 1
Type: Add-on Acquisition	1 of 1
State: California	1 of 1
Country: United States	1 of 1
Year: 2021	1 of 1

Explore Related M&A Activity

Life Science M&A - Add-on Acquisition M&A Deals - California M&A - United States M&A - 2021 M&A